KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Elanco Animal Health (ELAN) Operating Expenses: 2017-2025

Historic Operating Expenses for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to $440.0 million.

  • Elanco Animal Health's Operating Expenses fell 6.58% to $440.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year decrease of 39.68%. This contributed to the annual value of $4.0 billion for FY2024, which is 29.60% down from last year.
  • Per Elanco Animal Health's latest filing, its Operating Expenses stood at $440.0 million for Q3 2025, which was down 10.57% from $492.0 million recorded in Q2 2025.
  • Elanco Animal Health's 5-year Operating Expenses high stood at $2.2 billion for Q3 2023, and its period low was $435.0 million during Q1 2025.
  • Moreover, its 3-year median value for Operating Expenses was $1.1 billion (2023), whereas its average is $993.6 million.
  • As far as peak fluctuations go, Elanco Animal Health's Operating Expenses soared by 128.51% in 2021, and later crashed by 78.24% in 2024.
  • Over the past 5 years, Elanco Animal Health's Operating Expenses (Quarterly) stood at $1.2 billion in 2021, then declined by 13.18% to $1.1 billion in 2022, then rose by 8.19% to $1.2 billion in 2023, then fell by 7.83% to $1.1 billion in 2024, then declined by 6.58% to $440.0 million in 2025.
  • Its Operating Expenses was $440.0 million in Q3 2025, compared to $492.0 million in Q2 2025 and $435.0 million in Q1 2025.